NEW YORK, Dec. 14, 2016 -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Tyson Foods, Inc. (“Tyson” or the “Company”) (NYSE:TSN) and certain of its officers, on behalf of shareholders who purchased Tyson securities from November 23, 2015 and October 7, 2016, inclusive (the "Class Period").
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).
The complaint alleges that throughout the Class Period, defendants issued false and misleading statements and/or failed to disclose that Tyson Foods had devised to manipulate chicken prices and as a result, defendants’ statements were materially false and misleading at all relevant times. On September 2, 2016, news sources reported the filing of an antitrust lawsuit against Tyson Foods claiming that it conspired to change the price of broiler-chickens. On October 7, 2016, Pivotal Research downgraded Tyson from “buy” to “sell,” noting apprehensions about a "powerfully convincing" class action against Tyson and some of its industry peers as defendants, alleging price collusion in the broiler-chicken market. The complaint alleges that at the beginning of 2008, Tyson and several other companies conspired by sharing proprietary data and reducing production to support prices. Following this news, Tyson stock has dropped as much as $8.53, or 11.47%, to $65.85 during intraday trading on October 7, 2016.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/tsn or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email [email protected]. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Tyson you have until December 16, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact: Bronstein, Gewirtz & Grossman, LLC Peretz Bronstein or Yael Hurwitz 212-697-6484 | [email protected]


Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 



